

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * surfactant homeostasis (GO:0043129) | 5.20152467 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.60351408 |
| 3 | lymph vessel development (GO:0001945) | 4.35260364 |
| 4 | regulation of endothelial cell differentiation (GO:0045601) | 4.33227800 |
| 5 | lymphangiogenesis (GO:0001946) | 4.14076860 |
| 6 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.11137757 |
| 7 | * chemical homeostasis within a tissue (GO:0048875) | 4.07835442 |
| 8 | blood vessel maturation (GO:0001955) | 3.91026525 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 3.82572874 |
| 10 | regulation of vasculogenesis (GO:2001212) | 3.70864518 |
| 11 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.63832529 |
| 12 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.51949189 |
| 13 | endothelial tube morphogenesis (GO:0061154) | 3.39990466 |
| 14 | morphogenesis of an endothelium (GO:0003159) | 3.39990466 |
| 15 | endothelium development (GO:0003158) | 3.34572415 |
| 16 | positive regulation of vasculogenesis (GO:2001214) | 3.30203963 |
| 17 | apoptotic cell clearance (GO:0043277) | 3.28719317 |
| 18 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.27627352 |
| 19 | ethanol oxidation (GO:0006069) | 3.23441775 |
| 20 | endothelial cell morphogenesis (GO:0001886) | 3.22761233 |
| 21 | cell migration involved in heart development (GO:0060973) | 3.22652293 |
| 22 | hormone catabolic process (GO:0042447) | 3.21210707 |
| 23 | renal filtration (GO:0097205) | 3.18354314 |
| 24 | fatty acid transmembrane transport (GO:1902001) | 3.13864089 |
| 25 | endothelial cell differentiation (GO:0045446) | 3.13085464 |
| 26 | extracellular matrix assembly (GO:0085029) | 3.12039353 |
| 27 | protein heterotrimerization (GO:0070208) | 3.11362732 |
| 28 | glomerular filtration (GO:0003094) | 3.07373968 |
| 29 | cell-substrate junction assembly (GO:0007044) | 3.03949982 |
| 30 | negative regulation of complement activation (GO:0045916) | 3.02737063 |
| 31 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.01711688 |
| 32 | xenobiotic catabolic process (GO:0042178) | 3.01010294 |
| 33 | cell adhesion mediated by integrin (GO:0033627) | 3.00553344 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 2.99525656 |
| 35 | basement membrane organization (GO:0071711) | 2.99016952 |
| 36 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.98275159 |
| 37 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.92606341 |
| 38 | regulation of p38MAPK cascade (GO:1900744) | 2.89951745 |
| 39 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.89882813 |
| 40 | barbed-end actin filament capping (GO:0051016) | 2.87749867 |
| 41 | blood vessel endothelial cell migration (GO:0043534) | 2.86614158 |
| 42 | negative regulation of protein activation cascade (GO:2000258) | 2.85002673 |
| 43 | virion attachment to host cell (GO:0019062) | 2.84205143 |
| 44 | adhesion of symbiont to host cell (GO:0044650) | 2.84205143 |
| 45 | endodermal cell differentiation (GO:0035987) | 2.83367760 |
| 46 | extracellular fibril organization (GO:0043206) | 2.82054112 |
| 47 | toxin metabolic process (GO:0009404) | 2.81554071 |
| 48 | heart trabecula formation (GO:0060347) | 2.80409855 |
| 49 | positive regulation of p38MAPK cascade (GO:1900745) | 2.80069120 |
| 50 | skin morphogenesis (GO:0043589) | 2.79459661 |
| 51 | hemidesmosome assembly (GO:0031581) | 2.79356712 |
| 52 | venous blood vessel morphogenesis (GO:0048845) | 2.77647865 |
| 53 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.76496416 |
| 54 | patterning of blood vessels (GO:0001569) | 2.75256716 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 2.75099740 |
| 56 | positive regulation of extracellular matrix organization (GO:1903055) | 2.74363197 |
| 57 | endocrine hormone secretion (GO:0060986) | 2.74064867 |
| 58 | lung vasculature development (GO:0060426) | 2.73049925 |
| 59 | positive regulation of receptor recycling (GO:0001921) | 2.73030346 |
| 60 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.72729419 |
| 61 | regulation of complement activation (GO:0030449) | 2.72371538 |
| 62 | low-density lipoprotein particle clearance (GO:0034383) | 2.72127755 |
| 63 | regulation of protein activation cascade (GO:2000257) | 2.71996399 |
| 64 | carnitine shuttle (GO:0006853) | 2.71840529 |
| 65 | adhesion of symbiont to host (GO:0044406) | 2.68332310 |
| 66 | transcytosis (GO:0045056) | 2.67763083 |
| 67 | complement activation, alternative pathway (GO:0006957) | 2.67575890 |
| 68 | coronary vasculature morphogenesis (GO:0060977) | 2.65873681 |
| 69 | keratan sulfate catabolic process (GO:0042340) | 2.65846689 |
| 70 | adherens junction assembly (GO:0034333) | 2.64190190 |
| 71 | negative regulation of fatty acid transport (GO:2000192) | 2.61062970 |
| 72 | wound healing, spreading of epidermal cells (GO:0035313) | 2.60746357 |
| 73 | flavonoid metabolic process (GO:0009812) | 2.60576277 |
| 74 | regulation of sequestering of triglyceride (GO:0010889) | 2.60459354 |
| 75 | endothelial cell chemotaxis (GO:0035767) | 2.60329745 |
| 76 | fibril organization (GO:0097435) | 2.58365679 |
| 77 | atrioventricular valve morphogenesis (GO:0003181) | 2.56744204 |
| 78 | lung lobe morphogenesis (GO:0060463) | 2.56083243 |
| 79 | fatty acid beta-oxidation (GO:0006635) | 2.55343215 |
| 80 | cell-substrate adherens junction assembly (GO:0007045) | 2.55196561 |
| 81 | focal adhesion assembly (GO:0048041) | 2.55196561 |
| 82 | protein localization to endosome (GO:0036010) | 2.54725532 |
| 83 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.54333450 |
| 84 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.54041595 |
| 85 | type B pancreatic cell proliferation (GO:0044342) | 2.53783595 |
| 86 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.53538574 |
| 87 | cell volume homeostasis (GO:0006884) | 2.51955162 |
| 88 | endocardial cushion development (GO:0003197) | 2.51770784 |
| 89 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.51221056 |
| 90 | response to mercury ion (GO:0046689) | 2.50981124 |
| 91 | phenylpropanoid metabolic process (GO:0009698) | 2.49377375 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48896494 |
| 93 | lysine catabolic process (GO:0006554) | 2.48604486 |
| 94 | lysine metabolic process (GO:0006553) | 2.48604486 |
| 95 | ovulation from ovarian follicle (GO:0001542) | 2.48236648 |
| 96 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.48226436 |
| 97 | negative regulation of humoral immune response (GO:0002921) | 2.47454657 |
| 98 | positive regulation of fatty acid oxidation (GO:0046321) | 2.44712464 |
| 99 | glomerular visceral epithelial cell development (GO:0072015) | 2.44528638 |
| 100 | fatty acid oxidation (GO:0019395) | 2.44521861 |
| 101 | desmosome organization (GO:0002934) | 2.43890640 |
| 102 | drug metabolic process (GO:0017144) | 2.43365137 |
| 103 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.43272028 |
| 104 | omega-hydroxylase P450 pathway (GO:0097267) | 2.43049575 |
| 105 | glomerular epithelial cell development (GO:0072310) | 2.42499002 |
| 106 | collagen fibril organization (GO:0030199) | 2.40284229 |
| 107 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.40172710 |
| 108 | phospholipid homeostasis (GO:0055091) | 2.39906739 |
| 109 | lipid oxidation (GO:0034440) | 2.39898914 |
| 110 | regulation of fibrinolysis (GO:0051917) | 2.39458639 |
| 111 | regulation of apoptotic cell clearance (GO:2000425) | 2.38896847 |
| 112 | vasculogenesis (GO:0001570) | 2.38460183 |
| 113 | cell proliferation involved in metanephros development (GO:0072203) | 2.37112054 |
| 114 | regulation of cholesterol storage (GO:0010885) | 2.36371714 |
| 115 | ethanol metabolic process (GO:0006067) | 2.35011035 |
| 116 | artery development (GO:0060840) | 2.34174667 |
| 117 | regulation of cholesterol homeostasis (GO:2000188) | 2.33436359 |
| 118 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.32114303 |
| 119 | regulation of extracellular matrix disassembly (GO:0010715) | 2.32057932 |
| 120 | regulation of cardioblast differentiation (GO:0051890) | 2.31894193 |
| 121 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.31325935 |
| 122 | protein carboxylation (GO:0018214) | 2.31325935 |
| 123 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.31153436 |
| 124 | regulation of triglyceride catabolic process (GO:0010896) | 2.30928191 |
| 125 | sulfur amino acid catabolic process (GO:0000098) | 2.30538124 |
| 126 | gap junction assembly (GO:0016264) | 2.28600340 |
| 127 | sodium-independent organic anion transport (GO:0043252) | 2.28056021 |
| 128 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.27552453 |
| 129 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.27464051 |
| 130 | collagen metabolic process (GO:0032963) | 2.26633604 |
| 131 | negative regulation of platelet activation (GO:0010544) | 2.26432224 |
| 132 | response to xenobiotic stimulus (GO:0009410) | 2.26370877 |
| 133 | extracellular matrix disassembly (GO:0022617) | 2.26220817 |
| 134 | glomerular basement membrane development (GO:0032836) | 2.26077547 |
| 135 | regulation of skeletal muscle contraction (GO:0014819) | 2.26048346 |
| 136 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.25645916 |
| 137 | stress fiber assembly (GO:0043149) | 2.25627140 |
| 138 | regulation of glomerular filtration (GO:0003093) | 2.25333424 |
| 139 | regulation of fatty acid oxidation (GO:0046320) | 2.23641336 |
| 140 | hyaluronan catabolic process (GO:0030214) | 2.23117794 |
| 141 | negative regulation of endothelial cell migration (GO:0010596) | 2.23026221 |
| 142 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.22485623 |
| 143 | cAMP biosynthetic process (GO:0006171) | 2.22185390 |
| 144 | positive regulation of osteoblast proliferation (GO:0033690) | 2.21726225 |
| 145 | regulation of plasminogen activation (GO:0010755) | 2.21671839 |
| 146 | L-phenylalanine catabolic process (GO:0006559) | 2.21592755 |
| 147 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.21592755 |
| 148 | L-phenylalanine metabolic process (GO:0006558) | 2.21543187 |
| 149 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.21543187 |
| 150 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.20995582 |
| 151 | renal absorption (GO:0070293) | 2.20764803 |
| 152 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.20187781 |
| 153 | epithelial cell-cell adhesion (GO:0090136) | 2.20073777 |
| 154 | smooth muscle tissue development (GO:0048745) | 2.19795712 |
| 155 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.18777384 |
| 156 | chondrocyte proliferation (GO:0035988) | 2.15917384 |
| 157 | substrate-dependent cell migration (GO:0006929) | 2.14787664 |
| 158 | sprouting angiogenesis (GO:0002040) | 2.12692823 |
| 159 | extracellular matrix organization (GO:0030198) | 2.12320938 |
| 160 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.12041878 |
| 161 | extracellular structure organization (GO:0043062) | 2.11381830 |
| 162 | multicellular organismal metabolic process (GO:0044236) | 2.11373108 |
| 163 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.10433850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.64425690 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.95809736 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.01979317 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.86772200 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.85002644 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.62232457 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44640521 |
| 8 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30330780 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.28807418 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.27841359 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27450296 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.24856828 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.09107046 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.95787194 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.92764980 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90788508 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83089957 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82734828 |
| 19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.79587600 |
| 20 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73293291 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70460021 |
| 22 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.64072165 |
| 23 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.64072165 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60715037 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54651714 |
| 26 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53463412 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46743055 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44984003 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40149091 |
| 30 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40004917 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39154947 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38015948 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.38008379 |
| 34 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.36741011 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36624251 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36336936 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35490004 |
| 38 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32128839 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.28928877 |
| 40 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27666159 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27553187 |
| 42 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26617602 |
| 43 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26429644 |
| 44 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25110218 |
| 45 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25110218 |
| 46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23701469 |
| 47 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23701469 |
| 48 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23508594 |
| 49 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.22435138 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21142281 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20809504 |
| 52 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19993970 |
| 53 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.17860238 |
| 54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16805656 |
| 55 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15603090 |
| 56 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.15033776 |
| 57 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.14604031 |
| 58 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.14548293 |
| 59 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13474513 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12592153 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12464425 |
| 62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12407154 |
| 63 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.11780308 |
| 64 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.09792698 |
| 65 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09549197 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08264938 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06241811 |
| 68 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04616745 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04442166 |
| 70 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04420759 |
| 71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03686980 |
| 72 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.03195550 |
| 73 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02983260 |
| 74 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02438100 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02316098 |
| 76 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01996075 |
| 77 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01683783 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00885359 |
| 79 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00736562 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00691983 |
| 81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99198924 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98726042 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98726042 |
| 84 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98464226 |
| 85 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98423369 |
| 86 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.98086449 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98081044 |
| 88 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.98038096 |
| 89 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97560544 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96691942 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95998763 |
| 92 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95981508 |
| 93 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95807909 |
| 94 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95133108 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92230658 |
| 96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91782631 |
| 97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91708539 |
| 98 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.91309844 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90817003 |
| 100 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89636797 |
| 101 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89573466 |
| 102 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.89062128 |
| 103 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88882412 |
| 104 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.88446331 |
| 105 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87871217 |
| 106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85190923 |
| 107 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85103996 |
| 108 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85093401 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85060087 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84000531 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83978149 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82101294 |
| 113 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82080690 |
| 114 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81925807 |
| 115 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81809959 |
| 116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81397942 |
| 117 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81259693 |
| 118 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80331074 |
| 119 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79360144 |
| 120 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.77734307 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76447026 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.32040016 |
| 2 | MP0005167_abnormal_blood-brain_barrier | 4.15743154 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 3.96290203 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.46051454 |
| 5 | MP0004272_abnormal_basement_membrane | 3.28608569 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.08633578 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.95876621 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.84753268 |
| 9 | MP0001958_emphysema | 2.67364854 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.66467289 |
| 11 | MP0005360_urolithiasis | 2.53181327 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.46718041 |
| 13 | MP0005365_abnormal_bile_salt | 2.39475463 |
| 14 | MP0004782_abnormal_surfactant_physiolog | 2.31158846 |
| 15 | MP0003724_increased_susceptibility_to | 2.29646628 |
| 16 | MP0003828_pulmonary_edema | 2.21570903 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.14956311 |
| 18 | MP0004130_abnormal_muscle_cell | 2.14827763 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.00993888 |
| 20 | MP0005670_abnormal_white_adipose | 2.00147296 |
| 21 | MP0004036_abnormal_muscle_relaxation | 1.97344710 |
| 22 | MP0005023_abnormal_wound_healing | 1.94650801 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.87417624 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.85136971 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.80616423 |
| 26 | MP0003279_aneurysm | 1.72109939 |
| 27 | MP0005409_darkened_coat_color | 1.71955941 |
| 28 | * MP0006138_congestive_heart_failure | 1.70132765 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.63078991 |
| 30 | MP0001542_abnormal_bone_strength | 1.62073293 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.61072407 |
| 32 | MP0000767_abnormal_smooth_muscle | 1.60737267 |
| 33 | MP0006054_spinal_hemorrhage | 1.59378042 |
| 34 | MP0000751_myopathy | 1.57906438 |
| 35 | MP0005165_increased_susceptibility_to | 1.55684968 |
| 36 | * MP0001544_abnormal_cardiovascular_syste | 1.55262360 |
| 37 | * MP0005385_cardiovascular_system_phenoty | 1.55262360 |
| 38 | MP0003252_abnormal_bile_duct | 1.54963070 |
| 39 | MP0005330_cardiomyopathy | 1.54770015 |
| 40 | MP0002295_abnormal_pulmonary_circulatio | 1.54130583 |
| 41 | MP0004484_altered_response_of | 1.50333465 |
| 42 | MP0000343_altered_response_to | 1.48925745 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.48340030 |
| 44 | MP0005595_abnormal_vascular_smooth | 1.47317337 |
| 45 | MP0002108_abnormal_muscle_morphology | 1.44397064 |
| 46 | MP0005083_abnormal_biliary_tract | 1.43274254 |
| 47 | MP0002060_abnormal_skin_morphology | 1.38209155 |
| 48 | MP0009840_abnormal_foam_cell | 1.37862884 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.37198612 |
| 50 | MP0002972_abnormal_cardiac_muscle | 1.33467564 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.31787290 |
| 52 | MP0004883_abnormal_blood_vessel | 1.31372830 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.30161853 |
| 54 | MP0005332_abnormal_amino_acid | 1.29967395 |
| 55 | MP0010630_abnormal_cardiac_muscle | 1.29686169 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 1.29306720 |
| 57 | * MP0000249_abnormal_blood_vessel | 1.29104847 |
| 58 | MP0002877_abnormal_melanocyte_morpholog | 1.28424540 |
| 59 | MP0002896_abnormal_bone_mineralization | 1.27638883 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.25378166 |
| 61 | MP0005508_abnormal_skeleton_morphology | 1.23271227 |
| 62 | MP0005388_respiratory_system_phenotype | 1.21839174 |
| 63 | MP0002133_abnormal_respiratory_system | 1.21839174 |
| 64 | MP0003941_abnormal_skin_development | 1.20923902 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.19700058 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 1.15574908 |
| 67 | MP0005620_abnormal_muscle_contractility | 1.14997912 |
| 68 | MP0000230_abnormal_systemic_arterial | 1.14319035 |
| 69 | MP0004087_abnormal_muscle_fiber | 1.12561996 |
| 70 | MP0002933_joint_inflammation | 1.11630371 |
| 71 | MP0008004_abnormal_stomach_pH | 1.11251414 |
| 72 | * MP0002128_abnormal_blood_circulation | 1.09536192 |
| 73 | MP0003300_gastrointestinal_ulcer | 1.08987126 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.08709312 |
| 75 | * MP0004085_abnormal_heartbeat | 1.08447798 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.07744004 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.07323712 |
| 78 | MP0003075_altered_response_to | 1.06490155 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 1.06195472 |
| 80 | MP0005623_abnormal_meninges_morphology | 1.05381369 |
| 81 | MP0008995_early_reproductive_senescence | 1.04637567 |
| 82 | MP0005375_adipose_tissue_phenotype | 1.03466713 |
| 83 | MP0003690_abnormal_glial_cell | 1.02456704 |
| 84 | * MP0005164_abnormal_response_to | 1.02315166 |
| 85 | MP0004858_abnormal_nervous_system | 1.02267616 |
| 86 | MP0000013_abnormal_adipose_tissue | 1.01880342 |
| 87 | MP0001849_ear_inflammation | 0.99067509 |
| 88 | MP0001756_abnormal_urination | 0.98140610 |
| 89 | MP0003303_peritoneal_inflammation | 0.97749138 |
| 90 | MP0000609_abnormal_liver_physiology | 0.96937131 |
| 91 | MP0003868_abnormal_feces_composition | 0.95408349 |
| 92 | MP0009764_decreased_sensitivity_to | 0.95240428 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.93863436 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 0.93638193 |
| 95 | MP0003329_amyloid_beta_deposits | 0.92845813 |
| 96 | MP0002971_abnormal_brown_adipose | 0.91034619 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.89563191 |
| 98 | * MP0001614_abnormal_blood_vessel | 0.88599380 |
| 99 | MP0000749_muscle_degeneration | 0.88320970 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.87001241 |
| 101 | * MP0002925_abnormal_cardiovascular_devel | 0.85990959 |
| 102 | MP0002254_reproductive_system_inflammat | 0.85153815 |
| 103 | MP0003091_abnormal_cell_migration | 0.84957878 |
| 104 | MP0000759_abnormal_skeletal_muscle | 0.84557787 |
| 105 | MP0003646_muscle_fatigue | 0.84198571 |
| 106 | MP0001915_intracranial_hemorrhage | 0.82796242 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.82644804 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.81866011 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.79589758 |
| 110 | MP0002796_impaired_skin_barrier | 0.78971629 |
| 111 | MP0001851_eye_inflammation | 0.78929542 |
| 112 | MP0003045_fibrosis | 0.77921848 |
| 113 | MP0005166_decreased_susceptibility_to | 0.77683199 |
| 114 | MP0009115_abnormal_fat_cell | 0.77406022 |
| 115 | MP0005076_abnormal_cell_differentiation | 0.77163073 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.76974885 |
| 117 | MP0005390_skeleton_phenotype | 0.76397074 |
| 118 | MP0000762_abnormal_tongue_morphology | 0.75966590 |
| 119 | MP0001177_atelectasis | 0.75918359 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.75419587 |
| 121 | MP0001661_extended_life_span | 0.75102022 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.74931872 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74694049 |
| 124 | MP0005275_abnormal_skin_tensile | 0.74651829 |
| 125 | MP0000733_abnormal_muscle_development | 0.74403928 |
| 126 | MP0001666_abnormal_nutrient_absorption | 0.72703750 |
| 127 | MP0000750_abnormal_muscle_regeneration | 0.72146639 |
| 128 | * MP0000266_abnormal_heart_morphology | 0.70664824 |
| 129 | MP0000604_amyloidosis | 0.70124380 |
| 130 | MP0000467_abnormal_esophagus_morphology | 0.67302400 |
| 131 | MP0004510_myositis | 0.66389241 |
| 132 | MP0001243_abnormal_dermal_layer | 0.66170452 |
| 133 | MP0001175_abnormal_lung_morphology | 0.65487236 |
| 134 | MP0001533_abnormal_skeleton_physiology | 0.65365895 |
| 135 | MP0002168_other_aberrant_phenotype | 0.65250447 |
| 136 | MP0003448_altered_tumor_morphology | 0.64942201 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.64294374 |
| 138 | MP0010234_abnormal_vibrissa_follicle | 0.62890512 |
| 139 | MP0005647_abnormal_sex_gland | 0.62761553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 5.93507250 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.74764956 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.74639454 |
| 4 | * Polycythemia (HP:0001901) | 4.63438655 |
| 5 | Esophageal varix (HP:0002040) | 4.45697424 |
| 6 | Vascular tortuosity (HP:0004948) | 4.41370617 |
| 7 | Hematochezia (HP:0002573) | 4.25543395 |
| 8 | Arterial tortuosity (HP:0005116) | 4.07892289 |
| 9 | Spontaneous hematomas (HP:0007420) | 4.05796584 |
| 10 | Hyperactive renin-angiotensin system (HP:0000841) | 3.88092974 |
| 11 | Aortic dissection (HP:0002647) | 3.87940475 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.59510211 |
| 13 | Broad metatarsal (HP:0001783) | 3.46328091 |
| 14 | Visceral angiomatosis (HP:0100761) | 3.32437236 |
| 15 | Cerebral hemorrhage (HP:0001342) | 3.29464013 |
| 16 | Spinal rigidity (HP:0003306) | 3.24367813 |
| 17 | Complement deficiency (HP:0004431) | 3.18606769 |
| 18 | Cervical subluxation (HP:0003308) | 3.18489257 |
| 19 | Interstitial pulmonary disease (HP:0006530) | 3.18060945 |
| 20 | Type 1 muscle fiber predominance (HP:0003803) | 3.17340698 |
| 21 | Sudden death (HP:0001699) | 3.14313095 |
| 22 | Ankle contracture (HP:0006466) | 3.13146173 |
| 23 | Muscle fiber splitting (HP:0003555) | 3.12197404 |
| 24 | Wormian bones (HP:0002645) | 3.06858471 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 3.06266176 |
| 26 | Hemangiomatosis (HP:0007461) | 3.05812271 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 3.02492538 |
| 28 | Vertebral compression fractures (HP:0002953) | 3.01551948 |
| 29 | Ventricular tachycardia (HP:0004756) | 2.98142182 |
| 30 | Hypoglycemic coma (HP:0001325) | 2.96955849 |
| 31 | Cerebral aneurysm (HP:0004944) | 2.93961370 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 2.88581673 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 2.86289949 |
| 34 | Hyperkalemia (HP:0002153) | 2.86181749 |
| 35 | Atrophic scars (HP:0001075) | 2.86016205 |
| 36 | Xanthomatosis (HP:0000991) | 2.83422002 |
| 37 | Shallow orbits (HP:0000586) | 2.81927090 |
| 38 | Bladder diverticulum (HP:0000015) | 2.72340709 |
| 39 | Conjunctival telangiectasia (HP:0000524) | 2.70361522 |
| 40 | Lymphangioma (HP:0100764) | 2.70092681 |
| 41 | Hypoalphalipoproteinemia (HP:0003233) | 2.69950668 |
| 42 | Increased connective tissue (HP:0009025) | 2.69611188 |
| 43 | Growth hormone excess (HP:0000845) | 2.69453766 |
| 44 | Hyperglycinuria (HP:0003108) | 2.69192103 |
| 45 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.68087625 |
| 46 | Potter facies (HP:0002009) | 2.67232528 |
| 47 | Facial shape deformation (HP:0011334) | 2.67232528 |
| 48 | Pulmonary artery stenosis (HP:0004415) | 2.62776647 |
| 49 | Dilatation of the ascending aorta (HP:0005111) | 2.61122303 |
| 50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60863780 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.60835424 |
| 52 | Renal salt wasting (HP:0000127) | 2.60583639 |
| 53 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.60068201 |
| 54 | Osteolytic defects of the hand bones (HP:0009699) | 2.60068201 |
| 55 | Intrahepatic cholestasis (HP:0001406) | 2.59377961 |
| 56 | Gout (HP:0001997) | 2.58932372 |
| 57 | Soft skin (HP:0000977) | 2.56033109 |
| 58 | Follicular hyperkeratosis (HP:0007502) | 2.53168304 |
| 59 | Fragile skin (HP:0001030) | 2.51353229 |
| 60 | Mitral valve prolapse (HP:0001634) | 2.50194663 |
| 61 | Difficulty running (HP:0009046) | 2.48851191 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.47749411 |
| 63 | Atrial fibrillation (HP:0005110) | 2.45073200 |
| 64 | Atrioventricular block (HP:0001678) | 2.39943317 |
| 65 | Syncope (HP:0001279) | 2.39556440 |
| 66 | Mitral stenosis (HP:0001718) | 2.35500712 |
| 67 | Blue sclerae (HP:0000592) | 2.33599344 |
| 68 | Hyperammonemia (HP:0001987) | 2.33403819 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.32519492 |
| 70 | Exercise-induced myalgia (HP:0003738) | 2.31158610 |
| 71 | Stroke (HP:0001297) | 2.29779822 |
| 72 | Ketoacidosis (HP:0001993) | 2.29691781 |
| 73 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.28560808 |
| 74 | Cavernous hemangioma (HP:0001048) | 2.28276909 |
| 75 | Ketosis (HP:0001946) | 2.26579691 |
| 76 | Adactyly (HP:0009776) | 2.26435697 |
| 77 | Aneurysm (HP:0002617) | 2.25048539 |
| 78 | Bronchomalacia (HP:0002780) | 2.24993309 |
| 79 | Primary atrial arrhythmia (HP:0001692) | 2.24788598 |
| 80 | Supraventricular arrhythmia (HP:0005115) | 2.24147680 |
| 81 | Myoglobinuria (HP:0002913) | 2.23604449 |
| 82 | Abnormality of glycine metabolism (HP:0010895) | 2.23360809 |
| 83 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.23360809 |
| 84 | Overgrowth (HP:0001548) | 2.21893691 |
| 85 | Hyperaldosteronism (HP:0000859) | 2.20867086 |
| 86 | Joint hemorrhage (HP:0005261) | 2.20643071 |
| 87 | Glomerulonephritis (HP:0000099) | 2.20055443 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.17527879 |
| 89 | Mesangial abnormality (HP:0001966) | 2.16807660 |
| 90 | Neonatal short-limb short stature (HP:0008921) | 2.16548443 |
| 91 | Long toe (HP:0010511) | 2.15549761 |
| 92 | Wrist flexion contracture (HP:0001239) | 2.14992725 |
| 93 | Skin nodule (HP:0200036) | 2.13583314 |
| 94 | Striae distensae (HP:0001065) | 2.13200726 |
| 95 | Exercise-induced muscle cramps (HP:0003710) | 2.12875143 |
| 96 | Hypokalemic alkalosis (HP:0001949) | 2.11528351 |
| 97 | Acanthosis nigricans (HP:0000956) | 2.11526524 |
| 98 | Heart block (HP:0012722) | 2.10817944 |
| 99 | Portal hypertension (HP:0001409) | 2.10039357 |
| 100 | Joint laxity (HP:0001388) | 2.09786424 |
| 101 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.09192606 |
| 102 | Vascular calcification (HP:0004934) | 2.08733659 |
| 103 | Bundle branch block (HP:0011710) | 2.08392854 |
| 104 | Supraventricular tachycardia (HP:0004755) | 2.07936158 |
| 105 | Cardiovascular calcification (HP:0011915) | 2.05099176 |
| 106 | Obstructive sleep apnea (HP:0002870) | 2.05050651 |
| 107 | Mucopolysacchariduria (HP:0008155) | 2.04879983 |
| 108 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04879983 |
| 109 | Abnormality of complement system (HP:0005339) | 2.04624245 |
| 110 | Abnormality of renin-angiotensin system (HP:0000847) | 2.04567108 |
| 111 | Respiratory distress (HP:0002098) | 2.03503134 |
| 112 | Pigmentary retinal degeneration (HP:0001146) | 2.03394972 |
| 113 | Abnormal atrioventricular conduction (HP:0005150) | 2.03208623 |
| 114 | Lipoatrophy (HP:0100578) | 2.03201610 |
| 115 | Tubulointerstitial fibrosis (HP:0005576) | 2.02592803 |
| 116 | Aortic aneurysm (HP:0004942) | 2.02357235 |
| 117 | Mitral regurgitation (HP:0001653) | 2.00343910 |
| 118 | Aortic valve stenosis (HP:0001650) | 1.99302964 |
| 119 | Nephritis (HP:0000123) | 1.99207685 |
| 120 | Neurofibrillary tangles (HP:0002185) | 1.98783778 |
| 121 | Distal lower limb amyotrophy (HP:0008944) | 1.98371305 |
| 122 | Tachypnea (HP:0002789) | 1.98281055 |
| 123 | Slender build (HP:0001533) | 1.96826451 |
| 124 | Abnormality of dentin (HP:0010299) | 1.96583432 |
| 125 | Camptodactyly of toe (HP:0001836) | 1.96397041 |
| 126 | Joint stiffness (HP:0001387) | 1.96054201 |
| 127 | Abnormality of the acetabulum (HP:0003170) | 1.94502284 |
| 128 | Aortic regurgitation (HP:0001659) | 1.94430854 |
| 129 | Short hallux (HP:0010109) | 1.93923500 |
| 130 | Pulmonary embolism (HP:0002204) | 1.93670745 |
| 131 | Myocardial infarction (HP:0001658) | 1.93338340 |
| 132 | Spondylolisthesis (HP:0003302) | 1.92523028 |
| 133 | Short nail (HP:0001799) | 1.92232213 |
| 134 | Chronic bronchitis (HP:0004469) | 1.91301799 |
| 135 | Pulmonary hypertension (HP:0002092) | 1.90171188 |
| 136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90087273 |
| 137 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90087273 |
| 138 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90087273 |
| 139 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.89829118 |
| 140 | Increased variability in muscle fiber diameter (HP:0003557) | 1.89785975 |
| 141 | Hypolipoproteinemia (HP:0010981) | 1.89735930 |
| 142 | Abnormality of the intrinsic pathway (HP:0010989) | 1.87832091 |
| 143 | Hyperextensible skin (HP:0000974) | 1.87436705 |
| 144 | Asymmetric septal hypertrophy (HP:0001670) | 1.86862712 |
| 145 | Abnormality of purine metabolism (HP:0004352) | 1.86792748 |
| 146 | Delayed CNS myelination (HP:0002188) | 1.86691486 |
| 147 | Neonatal death (HP:0003811) | 1.86285427 |
| 148 | Axonal loss (HP:0003447) | 1.85886119 |
| 149 | Abnormality of chloride homeostasis (HP:0011422) | 1.85346878 |
| 150 | Glomerulosclerosis (HP:0000096) | 1.84879248 |
| 151 | Focal segmental glomerulosclerosis (HP:0000097) | 1.84782038 |
| 152 | Disproportionate tall stature (HP:0001519) | 1.83423158 |
| 153 | Abnormality of the common coagulation pathway (HP:0010990) | 1.83160188 |
| 154 | Abnormality of the hepatic vasculature (HP:0006707) | 1.82537054 |
| 155 | Venous abnormality (HP:0002624) | 1.82499649 |
| 156 | Chondrocalcinosis (HP:0000934) | 1.81747228 |
| 157 | Nuclear cataract (HP:0100018) | 1.80084834 |
| 158 | Hypoplasia of the iris (HP:0007676) | 1.78760242 |
| 159 | Elbow flexion contracture (HP:0002987) | 1.75733337 |
| 160 | Coxa vara (HP:0002812) | 1.75126155 |
| 161 | Peritonitis (HP:0002586) | 1.73036246 |
| 162 | Wide anterior fontanel (HP:0000260) | 1.72822370 |
| 163 | Nonimmune hydrops fetalis (HP:0001790) | 1.71956627 |
| 164 | Ectopia lentis (HP:0001083) | 1.71125429 |
| 165 | Natal tooth (HP:0000695) | 1.69357525 |
| 166 | Dysostosis multiplex (HP:0000943) | 1.68001651 |
| 167 | Ovoid vertebral bodies (HP:0003300) | 1.67736081 |
| 168 | Advanced eruption of teeth (HP:0006288) | 1.66158075 |
| 169 | Glucose intolerance (HP:0000833) | 1.66045903 |
| 170 | Ulnar bowing (HP:0003031) | 1.64829978 |
| 171 | Upper limb amyotrophy (HP:0009129) | 1.64226695 |
| 172 | Distal upper limb amyotrophy (HP:0007149) | 1.64226695 |
| 173 | Cerebral inclusion bodies (HP:0100314) | 1.63696620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 8.03999261 |
| 2 | KDR | 3.69699244 |
| 3 | TGFBR2 | 3.53715368 |
| 4 | RIPK1 | 2.72511992 |
| 5 | TRIB3 | 2.53812040 |
| 6 | EPHB2 | 2.30617442 |
| 7 | LATS2 | 2.16988584 |
| 8 | ERN1 | 2.08709948 |
| 9 | MYLK | 2.05998900 |
| 10 | EPHB1 | 1.90864435 |
| 11 | FGFR4 | 1.87515875 |
| 12 | PDGFRA | 1.74505433 |
| 13 | TTN | 1.64237451 |
| 14 | TESK1 | 1.61148175 |
| 15 | FER | 1.57357540 |
| 16 | CDC42BPA | 1.57204786 |
| 17 | GRK1 | 1.55579931 |
| 18 | FGFR2 | 1.53045718 |
| 19 | TGFBR1 | 1.51262187 |
| 20 | DMPK | 1.50331945 |
| 21 | LMTK2 | 1.48625433 |
| 22 | BCKDK | 1.45498766 |
| 23 | SIK1 | 1.41785716 |
| 24 | MAP3K3 | 1.33102308 |
| 25 | TRPM7 | 1.32466573 |
| 26 | PDK2 | 1.31536605 |
| 27 | PTK2B | 1.29795153 |
| 28 | PTK6 | 1.24229977 |
| 29 | MAP3K6 | 1.24031918 |
| 30 | ICK | 1.22407721 |
| 31 | INSRR | 1.20513083 |
| 32 | PRPF4B | 1.19464423 |
| 33 | PAK2 | 1.18253420 |
| 34 | PHKG2 | 1.16205140 |
| 35 | PHKG1 | 1.16205140 |
| 36 | CAMK1D | 1.15917999 |
| 37 | MAP2K3 | 1.15053300 |
| 38 | MAPKAPK3 | 1.07813597 |
| 39 | EEF2K | 1.07453739 |
| 40 | PKN2 | 1.06070898 |
| 41 | WNK4 | 1.04600676 |
| 42 | CAMK1G | 1.00716590 |
| 43 | RPS6KA2 | 0.95893014 |
| 44 | MAPK15 | 0.95763371 |
| 45 | PAK4 | 0.95021965 |
| 46 | FGFR3 | 0.94853801 |
| 47 | DAPK2 | 0.94825458 |
| 48 | LATS1 | 0.92774619 |
| 49 | PDGFRB | 0.91721205 |
| 50 | PINK1 | 0.91005712 |
| 51 | ABL2 | 0.90656467 |
| 52 | PRKG2 | 0.88293511 |
| 53 | PRKD3 | 0.87890170 |
| 54 | AKT3 | 0.87459489 |
| 55 | MTOR | 0.86004197 |
| 56 | PRKCH | 0.85546373 |
| 57 | LRRK2 | 0.85520145 |
| 58 | MAP3K7 | 0.85301876 |
| 59 | GRK5 | 0.82989605 |
| 60 | PDK4 | 0.82914885 |
| 61 | PDK3 | 0.82914885 |
| 62 | PRKAA2 | 0.82454151 |
| 63 | MAPK12 | 0.81301595 |
| 64 | ERBB4 | 0.80666813 |
| 65 | EPHA3 | 0.80150336 |
| 66 | * PRKD1 | 0.78558302 |
| 67 | PAK3 | 0.78171204 |
| 68 | CDK12 | 0.77766476 |
| 69 | MAP3K13 | 0.77187989 |
| 70 | CSK | 0.76252203 |
| 71 | MAP3K2 | 0.75247799 |
| 72 | TYRO3 | 0.75219830 |
| 73 | MOS | 0.73496264 |
| 74 | ZAP70 | 0.73332240 |
| 75 | SGK3 | 0.71437222 |
| 76 | GSK3A | 0.71148583 |
| 77 | STK39 | 0.69832559 |
| 78 | EPHA2 | 0.69737803 |
| 79 | LIMK1 | 0.69235808 |
| 80 | PTK2 | 0.68740673 |
| 81 | ROCK2 | 0.68124756 |
| 82 | MAP3K1 | 0.64664498 |
| 83 | JAK1 | 0.63006464 |
| 84 | MAP2K2 | 0.62735062 |
| 85 | STK24 | 0.62636902 |
| 86 | MAP2K1 | 0.61758780 |
| 87 | SMG1 | 0.58935469 |
| 88 | NEK9 | 0.57302887 |
| 89 | MET | 0.57099353 |
| 90 | OBSCN | 0.56519179 |
| 91 | MST1R | 0.56415921 |
| 92 | RET | 0.56266193 |
| 93 | ARAF | 0.56150638 |
| 94 | IRAK3 | 0.55444856 |
| 95 | MAPK4 | 0.54872294 |
| 96 | CAMK2G | 0.54769532 |
| 97 | SGK223 | 0.52181686 |
| 98 | SGK494 | 0.52181686 |
| 99 | CAMK4 | 0.51472076 |
| 100 | TBK1 | 0.48670545 |
| 101 | ROCK1 | 0.47454535 |
| 102 | TYK2 | 0.47168674 |
| 103 | STK10 | 0.46118393 |
| 104 | MARK2 | 0.45950245 |
| 105 | MAPK7 | 0.45949212 |
| 106 | SGK2 | 0.45612145 |
| 107 | JAK2 | 0.45254054 |
| 108 | KIT | 0.44636973 |
| 109 | STK38L | 0.44032476 |
| 110 | DAPK3 | 0.43895110 |
| 111 | SRC | 0.42867353 |
| 112 | TAOK1 | 0.42298015 |
| 113 | FRK | 0.41741748 |
| 114 | MAP3K11 | 0.41294239 |
| 115 | STK38 | 0.41288828 |
| 116 | GRK7 | 0.40996759 |
| 117 | IGF1R | 0.40682584 |
| 118 | PRKD2 | 0.40062495 |
| 119 | CAMK1 | 0.40016886 |
| 120 | PIK3CA | 0.39937999 |
| 121 | RPS6KL1 | 0.39808947 |
| 122 | RPS6KC1 | 0.39808947 |
| 123 | NLK | 0.39613322 |
| 124 | EGFR | 0.39172518 |
| 125 | ILK | 0.38625247 |
| 126 | PRKAA1 | 0.37456901 |
| 127 | MAP2K4 | 0.37285435 |
| 128 | HIPK2 | 0.37147377 |
| 129 | ADRBK1 | 0.36275829 |
| 130 | CDK6 | 0.36075503 |
| 131 | * PDPK1 | 0.35434506 |
| 132 | PDK1 | 0.35292677 |
| 133 | DDR2 | 0.35146898 |
| 134 | WNK1 | 0.34767148 |
| 135 | MAPK11 | 0.34611253 |
| 136 | PRKCE | 0.34264687 |
| 137 | KSR2 | 0.33664905 |
| 138 | BMX | 0.33241295 |
| 139 | NTRK1 | 0.33135617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41852497 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54762644 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.22813722 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14930929 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.13743319 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.09880757 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.09646488 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06832795 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05105318 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01526699 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00981964 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.00321150 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98884062 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97811347 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89322456 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.88037218 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.69904269 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67599403 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59725210 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58984129 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57823258 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50118035 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44372858 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.43675539 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.42782461 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.36841812 |
| 27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.36003636 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31474346 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.31471263 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30357784 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25018172 |
| 32 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.23989127 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.23527400 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21231570 |
| 35 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18052435 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.14776300 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 1.08995646 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.08091122 |
| 39 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.07043995 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05924486 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.05794057 |
| 42 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.03988551 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03266897 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.03078099 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02643461 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.01162236 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97118282 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96961972 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95689711 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95351442 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92663804 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90313461 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89931865 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 0.89128971 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87647926 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.87088345 |
| 57 | Bladder cancer_Homo sapiens_hsa05219 | 0.86588811 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.85943952 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.84975297 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.82689423 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82595782 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79039380 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78890377 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74753982 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73998202 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73872260 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73811590 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71784360 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70051955 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.68356567 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.67156495 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67015216 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66826554 |
| 74 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65970917 |
| 75 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65935738 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65788183 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.62529869 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62375608 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61514749 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60563507 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.59353988 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59310432 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58779613 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.57449726 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57096856 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56699941 |
| 87 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.56293721 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55444445 |
| 89 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55194513 |
| 90 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54202544 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.54100504 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53877945 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53421065 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52198012 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52073609 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51796898 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51361522 |
| 98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51349313 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50931432 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50033212 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.49543051 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.49403574 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49373731 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48575846 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48430010 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47425191 |
| 107 | Salivary secretion_Homo sapiens_hsa04970 | 0.47135852 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.46494127 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45421268 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45276264 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45097011 |
| 112 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45020152 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44779049 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44719322 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44614384 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43939456 |
| 117 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43596968 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43185594 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.42724493 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42365318 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41106049 |
| 122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38634252 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38254829 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37894257 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.35630678 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35264081 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.34315385 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33599807 |
| 129 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32692710 |
| 130 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.32373800 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32272564 |
| 132 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32051582 |
| 133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31619583 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31463604 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31410032 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30792289 |
| 137 | Gap junction_Homo sapiens_hsa04540 | 0.29638670 |
| 138 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29461933 |
| 139 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29183902 |

